Bessemer Group’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-4,455	Closed	-$288K	–	1422
2013 Q4	$288K	Buy	4,455 +261	+6%	+$16.9K	﹤0.01%	618
2013 Q3	$267K	Hold	4,194	–	–	﹤0.01%	624
2013 Q2	$176K	Buy	+4,194	New	+$176K	﹤0.01%	580